Clinical Trial Update: Treatment of Keratoconus With Advanced CXL-II [Phase 2]

View source ↗

Summary

Phase 2 trial from Umeå University evaluating Advanced CXL-II for keratoconus; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Keratoconus

Snippet

Sponsor: Umeå University | Conditions: Keratoconus | Phase 2 | Status: UNKNOWN